“399V–6. Neglected tropical disease centers of excellence
“(a) Cooperative Agreements and Grants
“(1) In general—The Secretary, acting through the Director of the National Institute of Allergy and Infectious Diseases or the Administrator of the Health Resources and Services Administration, as appropriate, may enter into cooperative agreements with, and make grants to, public or private nonprofit entities to pay all or part of the cost of planning, establishing, or strengthening, and providing basic operating support for, one or more centers of excellence for research into, training in, and development of diagnosis, prevention, control, and treatment methods for neglected tropical diseases.
“(2) Eligibility—To be eligible for a cooperative agreement or grant under this section, an entity must—
“(A) have demonstrated expertise in research on, and the epidemiology and surveillance of, the major neglected tropical diseases that are endemic to the United States, such as Chagas disease, dengue, leishmaniasis, and West Nile virus infection, and helminth infections; and
“(B) participate in one or more not-for-profit product development partnerships.
“(b) Policies—A cooperative agreement or grant under paragraph (1) shall be entered into or awarded in accordance with policies established by the Director of the National Institutes of Health or the Health Resources and Services Administration, as applicable.
“(c) Coordination with other institutes—The Secretary shall coordinate the activities under this section with similar activities conducted by other national research institutes, centers, and agencies of the National Institutes of Health to the extent that such institutes, centers, and agencies have responsibilities that are related to neglected tropical diseases.
“(d) Uses of funds—A cooperative agreement or grant under subsection (a) may be used for—
“(1) staffing, administrative, and other basic operating costs, including such patient care costs as are required for research;
“(2) clinical training, including training for allied health professionals, continuing education for health professionals and allied health professions personnel, and information programs for the public with respect to neglected tropical diseases; and
“(3) research and development programs.
“(e) Period of Support; Additional Periods
“(1) In general—Support of a center of excellence under this section may be for a period of not more than 5 years.
“(2) Extensions—The period specified in paragraph (1) may be extended by the Secretary for additional periods of not more than 5 years if—
“(A) the operations of the center of excellence involved have been reviewed by an appropriate technical and scientific peer review group; and
“(B) such group has recommended to the Secretary that such period should be extended.
“(f) Definitions—In this section:
“(1) The term neglected tropical disease has the meaning given to that term in section 5 of the End Neglected Tropical Diseases Act.
“(2) The term product development partnership means a partnership to bring together public and private sector researchers to develop new, or improve on current, global health tools, such as drugs, diagnostics, insecticides, vaccines, and vector management strategies—
“(A) that are for neglected tropical diseases; and
“(B) for which there is generally no profitable market.
“(g) Authorization of appropriations—To carry out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2015 through 2019.”